Leukemia & Lymphoma, Volume 58, Issue 11 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 58, Issue 11 (2017)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Volume 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

G6PD deficiency and fungal infections in patients with acute myeloid leukemia: less enzyme more fungus
Anat Gafter-Gvili
Pages: 2519-2520
Published online: 31 May 2017
CitationforG6PD deficiency and fungal infections in patients with acute myeloid leukemia: less enzyme more fungus | Full Text | References | PDF (258 KB)
  • 135 Views
  • 1 CrossRef citations
  • 0Altmetric
MRD in AML: a role for detecting leukemic blasts at day 14 post-induction chemotherapy?
Michael Kluk
Pages: 2521-2522
Published online: 16 May 2017
CitationforMRD in AML: a role for detecting leukemic blasts at day 14 post-induction chemotherapy? | Full Text | References | PDF (250 KB) | Supplemental
  • 175 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Immunotherapy of elderly acute myeloid leukemia: light at the end of a long tunnel?
William M. Rafelson, John L. Reagan, Loren D. Fast & Seah H. Lim
Pages: 2523-2531
Published online: 28 Mar 2017
AbstractforImmunotherapy of elderly acute myeloid leukemia: light at the end of a long tunnel? | Full Text | References | PDF (993.5 KB) | Supplemental
  • 398 Views
  • 3 CrossRef citations
  • 0Altmetric
Prognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failure
Sagar S. Patel, Mikkael A. Sekeres & Aziz Nazha
Pages: 2532-2539
Published online: 28 Mar 2017
AbstractforPrognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failure | Full Text | References | PDF (756.6 KB) | Supplemental
  • 363 Views
  • 4 CrossRef citations
  • 0Altmetric
HiJAKing the epigenome in leukemia and lymphoma
Amanda C. Drennan & Lixin Rui
Pages: 2540-2547
Published online: 12 Apr 2017
AbstractforHiJAKing the epigenome in leukemia and lymphoma | Full Text | References | PDF (929.4 KB) | Supplemental
  • 306 Views
  • 3 CrossRef citations
  • 0Altmetric

Emerging drug profiles

Pralatrexate: a comprehensive update on pharmacology, clinical activity and strategies to optimize use
Owen A. O’Connor, Jennifer Amengual, Donald Colbourn, Changchun Deng & Ahmed Sawas
Pages: 2548-2557
Published online: 25 Jul 2017
AbstractforPralatrexate: a comprehensive update on pharmacology, clinical activity and strategies to optimize use | Full Text | References | PDF (932.9 KB)
  • 818 Views
  • 16 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia
Marco Sanna, Giovanni Caocci, Antonio Ledda, Federica Orrù, Claudio Fozza, Paola Deias, Gianni Tidore, Fausto Dore & Giorgio La Nasa
Pages: 2558-2564
Published online: 12 Apr 2017
AbstractforGlucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia | Full Text | References | PDF (613 KB) | Supplemental
  • 341 Views
  • 5 CrossRef citations
  • 0Altmetric
Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine
Ronald W. Heisel, Robert R. Sutton, Gerard P. Mascara, Daniel G. Winger, David R. Weber, Seah H. Lim & Louise-Marie Oleksiuk
Pages: 2565-2572
Published online: 28 Mar 2017
AbstractforVancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine | Full Text | References | PDF (895.6 KB)
  • 270 Views
  • 8 CrossRef citations
  • 0Altmetric
Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort
Damon E. Houghton, Nigel S. Key, Neil A. Zakai, Jeffrey P. Laux, Thomas C. Shea & Stephan Moll
Pages: 2573-2581
Published online: 09 Apr 2017
AbstractforAnalysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort | Full Text | References | PDF (1 MB) | Supplemental
  • 708 Views
  • 29 CrossRef citations
  • 0Altmetric
The presence of monoclonal gammopathy in Ph-negative myeloproliferative neoplasms is associated with a detrimental effect on outcomes
Lenaïg Le Clech, Mehdi Sakka, Ahmed Meskar, Helene Kerspern, Jean-Richard Eveillard, Christian Berthou, Caroline Buors, Eric Lippert, Gaelle Guillerm, Isabelle Quintin-Roué, Jean-Luc Carré & Jean-Christophe Ianotto
Pages: 2582-2587
Published online: 09 May 2017
AbstractforThe presence of monoclonal gammopathy in Ph-negative myeloproliferative neoplasms is associated with a detrimental effect on outcomes | Full Text | References | PDF (815.1 KB) | Supplemental
  • 295 Views
  • 9 CrossRef citations
  • 0Altmetric
Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy
Jason N. Barreto, Kristen B. McCullough, Candy S. Peskey, Ross A. Dierkhising, Kristin C. Mara, Michelle A. Elliott, Dennis A. Gastineau, Aref Al-Kali, Naseema Gangat, Louis Letendre, William J. Hogan, Mark R. Litzow & Mrinal M. Patnaik
Pages: 2588-2597
Published online: 09 May 2017
AbstractforSafety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy | Full Text | References | PDF (1.5 MB) | Supplemental
  • 327 Views
  • 11 CrossRef citations
  • 0Altmetric
Risk and impact of tuberculosis in patients with multiple myeloma*
Chun-Kuang Tsai, Leh-Kiong Huon, Shuo-Ming Ou, Ai-Seon Kuan, Chiu-Mei Yeh, Yu-Ting Lee, Yao-Chung Liu, Tzeng-Ji Chen, Jin-Hwang Liu & Chia-Jen Liu
Pages: 2598-2606
Published online: 09 May 2017
AbstractforRisk and impact of tuberculosis in patients with multiple myeloma* | Full Text | References | PDF (1 MB) | Supplemental
  • 327 Views
  • 6 CrossRef citations
  • 0Altmetric
Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma
Haowei (Linda) Sun, Eshetu G. Atenafu, Richard Tsang, Vishal Kukreti, Theodore K. Marras, Michael Crump & John Kuruvilla
Pages: 2607-2614
Published online: 15 May 2017
AbstractforBleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma | Full Text | References | PDF (801.6 KB) | Supplemental
  • 377 Views
  • 13 CrossRef citations
  • 0Altmetric
A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone
Véronique Leblond, Pierre Morel, Marie-Sarah Dilhuidy, Xavier Leleu, Carole Soussain, Stéphane Leprête, Brigitte Dreyfus, Caroline Dartigeas, Béatrice Mahé, Bruno Anglaret, Brigitte Pégourié, Caroline Besson, Thérèse Aurran, Anne Vekhoff, Olivier Tournilhac, Anne Banos, Hervé Oya, Julie Lejeune, Maya Ouzegdouh, Sylvie Chevret & on behalf of French Innovative Leukemia Organization (FILO)
Pages: 2615-2623
Published online: 10 Apr 2017
AbstractforA phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone | Full Text | References | PDF (1.1 MB) | Supplemental
  • 300 Views
  • 8 CrossRef citations
  • 0Altmetric
Diagnosis of secondary peripheral neurolymphomatosis: a multi-center experience
Ja Min Byun, Ki Hwan Kim, Miso Kim, Tae Min Kim, Yoon Kyung Jeon, Jeong Hwan Park, Jin Ho Paik, Jung Min Lee, Ho-Young Lee, Jong Seok Lee, Dae Seog Heo & Jeong-Ok Lee
Pages: 2624-2632
Published online: 09 May 2017
AbstractforDiagnosis of secondary peripheral neurolymphomatosis: a multi-center experience | Full Text | References | PDF (1.4 MB) | Supplemental
  • 453 Views
  • 8 CrossRef citations
  • 0Altmetric
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients
Giovanni D’Arena, Vittorio Simeon, Luca Laurenti, Michele Cimminiello, Idanna Innocenti, Michele Gilio, Angela Padula, Maria Luigia Vigliotti, Sonya De Lorenzo, Giacomo Loseto, Anna Passarelli, Matteo Nicola Dario Di Minno, Marco Tucci, Vincenzo De Feo, Fiorella D’Auria, Francesco Silvestris, Giovanni Di Minno & Pellegrino Musto
Pages: 2633-2641
Published online: 03 Apr 2017
AbstractforAdverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients | Full Text | References | PDF (1.1 MB) | Supplemental
  • 740 Views
  • 16 CrossRef citations
  • 0Altmetric

Original Articles: Research

FcγRIIb expression in early stage chronic lymphocytic leukemia
Rosa Bosch, Alba Mora, Eva Puy Vicente, Gerardo Ferrer, Sonia Jansà, Rajendra Damle, Sergey Gorlatov, Kanti Rai, Emili Montserrat, Josep Nomdedeu, Marta Pratcorona, Laura Blanco, Silvana Saavedra, Ana Garrido, Albert Esquirol, Irene Garcia, Miquel Granell, Rodrigo Martino, Julio Delgado, Jorge Sierra, Nicholas Chiorazzi & Carol Moreno
Pages: 2642-2648
Published online: 04 Apr 2017
AbstractforFcγRIIb expression in early stage chronic lymphocytic leukemia | Full Text | References | PDF (831.4 KB) | Supplemental
  • 293 Views
  • 7 CrossRef citations
  • 0Altmetric
Patterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromes
Amy E. DeZern, Gary Binder, Syed Rizvi, Frank A. Corvino, Steven R. Arikian, Andy Surinach, Jianyi Lee & B. Douglas Smith
Pages: 2649-2656
Published online: 09 May 2017
AbstractforPatterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromes | Full Text | References | PDF (1.1 MB) | Supplemental
  • 663 Views
  • 15 CrossRef citations
  • 0Altmetric
MicroRNA-185-5p restores glucocorticoid sensitivity by suppressing the mammalian target of rapamycin complex (mTORC) signaling pathway to enhance glucocorticoid receptor autoregulation
Peisong Chen, Ting Shen, Huimin Wang, Zhiyong Ke, Yaru Liang, Juan Ouyang & Tang Jiang
Pages: 2657-2667
Published online: 28 Feb 2017
AbstractforMicroRNA-185-5p restores glucocorticoid sensitivity by suppressing the mammalian target of rapamycin complex (mTORC) signaling pathway to enhance glucocorticoid receptor autoregulation | Full Text | References | PDF (1.5 MB) | Supplemental
  • 231 Views
  • 10 CrossRef citations
  • 0Altmetric
Mesenchymal stromal cells enhance the suppressive effects ofmyeloid-derived suppressor cells of multiple myeloma
Yinhui Xu, Xiaoying Zhang, Hongbo Liu, Pan Zhao, Yafang Chen, Yimin Luo, Zhiqing Zhang & Xiaofang Wang
Pages: 2668-2676
Published online: 20 Mar 2017
AbstractforMesenchymal stromal cells enhance the suppressive effects ofmyeloid-derived suppressor cells of multiple myeloma | Full Text | References | PDF (1.2 MB) | Supplemental
  • 325 Views
  • 10 CrossRef citations
  • 0Altmetric
Adverse prognostic impact of vascular endothelial growth factor gene polymorphisms in patients with diffuse large B-cell lymphoma
Kyong-Ah Yoon, Min Kyeong Kim, Hyeon-Seok Eom, Hyewon Lee, Weon Seo Park, Ji Yeon Sohn, Man Jin Kim & Sun-Young Kong
Pages: 2677-2682
Published online: 22 Mar 2017
AbstractforAdverse prognostic impact of vascular endothelial growth factor gene polymorphisms in patients with diffuse large B-cell lymphoma | Full Text | References | PDF (731.2 KB) | Supplemental
  • 216 Views
  • 6 CrossRef citations
  • 0Altmetric
Gene expression analysis of hypersensitivity to mosquito bite, chronic active EBV infection and NK/T-lymphoma/leukemia
Kana Washio, Takashi Oka, Lamia Abdalkader, Michiko Muraoka, Akira Shimada, Megumi Oda, Hiaki Sato, Katsuyoshi Takata, Yoshitoyo Kagami, Norio Shimizu, Seiichi Kato, Hiroshi Kimura, Kazunori Nishizaki, Tadashi Yoshino & Hirokazu Tsukahara
Pages: 2683-2694
Published online: 03 Apr 2017
AbstractforGene expression analysis of hypersensitivity to mosquito bite, chronic active EBV infection and NK/T-lymphoma/leukemia | Full Text | References | PDF (2.4 MB) | Supplemental
  • 501 Views
  • 5 CrossRef citations
  • 0Altmetric
Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival
Kaspar René Nielsen, Maria Rodrigo-Domingo, Rudi Steffensen, John Baech, Kim S Bergkvist, Liesbeth Oosterhof, Alexander Schmitz, Julie Støve Bødker, Preben Johansen, Ulla Vogel, Anette Vangsted, Karen Dybkær, Martin Bøgsted & Hans Erik Johnsen
Pages: 2695-2704
Published online: 09 Apr 2017
AbstractforInteractions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival | Full Text | References | PDF (1.1 MB) | Supplemental
  • 381 Views
  • 10 CrossRef citations
  • 0Altmetric
The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells
Benigno C. Valdez, Yang Li, David Murray, Yan Liu, Yago Nieto, Richard E. Champlin & Borje S. Andersson
Pages: 2705-2716
Published online: 10 Apr 2017
AbstractforThe PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells | Full Text | References | PDF (1.8 MB) | Supplemental
  • 392 Views
  • 5 CrossRef citations
  • 0Altmetric

Letters to the Editor

Flow cytometric demonstration of decrease in bone marrow leukemic blasts after ‘Day 14’ without further therapy in acute myeloid leukemia
Xueyan Chen, Megan Othus, Brent L. Wood, Roland B. Walter, Mary-Elizabeth M. Percival, Pamela S. Becker, Paul C. Hendrie, Frederick R. Appelbaum & Elihu H. Estey
Pages: 2717-2719
Published online: 28 Mar 2017
First Page PreviewforFlow cytometric demonstration of decrease in bone marrow leukemic blasts after ‘Day 14’ without further therapy in acute myeloid leukemia | Full Text | References | PDF (318.6 KB) | Supplemental
  • 284 Views
  • 6 CrossRef citations
  • 0Altmetric
The positive effect of deferasirox on erythropoiesis in a patient with a dual diagnosis of myelofibrosis and diffuse large B-cell lymphoma
Louise Kostos, Khai Li Chai, Constantine S. Tam & Ali Bazargan
Pages: 2720-2723
Published online: 23 Mar 2017
First Page PreviewforThe positive effect of deferasirox on erythropoiesis in a patient with a dual diagnosis of myelofibrosis and diffuse large B-cell lymphoma | Full Text | References | PDF (973.5 KB) | Supplemental
  • 194 Views
  • 1 CrossRef citations
  • 0Altmetric
Peripheral blood stem cell mobilization with a single dose of PEG-filgrastim in patients with multiple myeloma previously treated with radiotherapy
Alfonso T. Anguita-Compagnon, Maria T. Dibarrart, Laura Paredes, Daniel Araos, Marcela Vargas & Alejandro Majlis
Pages: 2724-2727
Published online: 16 Mar 2017
First Page PreviewforPeripheral blood stem cell mobilization with a single dose of PEG-filgrastim in patients with multiple myeloma previously treated with radiotherapy | Full Text | References | PDF (378.1 KB) | Supplemental
  • 151 Views
  • 1 CrossRef citations
  • 0Altmetric
Creation of a human T-ALL cell line online database
Barbara Squiban, Syed Talha Ahmed & J. Kimble Frazer
Pages: 2728-2730
Published online: 13 Jun 2017
First Page PreviewforCreation of a human T-ALL cell line online database | Full Text | References | PDF (311.3 KB) | Supplemental
  • 501 Views
  • 5 CrossRef citations
  • 0Altmetric
Serum C-reactive protein levels affect the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients
Takeo Yasu, Takaaki Konuma, Seiko Kato, Yosuke Kurokawa, Satoshi Takahashi & Arinobu Tojo
Pages: 2731-2733
Published online: 17 Mar 2017
First Page PreviewforSerum C-reactive protein levels affect the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients | Full Text | References | PDF (454.4 KB) | Supplemental
  • 338 Views
  • 21 CrossRef citations
  • 0Altmetric
Hepatosplenic T-cell lymphoma associated with membranoproliferative glomerulonephritis
Shuo-Chieh Wu, Jennifer R. Chapman, Francisco Vega, Neil Abrahams, Izidore S. Lossos & Juan Pablo Alderuccio
Pages: 2734-2737
Published online: 28 Mar 2017
First Page PreviewforHepatosplenic T-cell lymphoma associated with membranoproliferative glomerulonephritis | Full Text | References | PDF (1 MB) | Supplemental
  • 182 Views
  • 1 CrossRef citations
  • 0Altmetric
Bortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients: update of multicenter, open-label Phase 1/2 study
Sara Grammatico, Sara Bringhen, Federico Vozella, Agostina Siniscalchi, Mario Boccadoro & Maria Teresa Petrucci
Pages: 2738-2740
Published online: 12 Apr 2017
First Page PreviewforBortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients: update of multicenter, open-label Phase 1/2 study | Full Text | References | PDF (364.1 KB) | Supplemental
  • 255 Views
  • 1 CrossRef citations
  • 0Altmetric
Genesis of new allele at locus D2S1360 in leukemia patient
Blanka Robesova, Ivana Jeziskova, Marta Krejci, Jiri Mayer & Dana Dvorakova
Pages: 2741-2744
Published online: 03 Apr 2017
First Page PreviewforGenesis of new allele at locus D2S1360 in leukemia patient | Full Text | References | PDF (597.8 KB) | Supplemental
  • 81 Views
  • 0 CrossRef citations
  • 0Altmetric
Bendamustine as a bridge to allogeneic transplant in relapsed/refractory Hodgkin lymphoma patients who failed salvage brentuximab vedotin postautologous peripheral blood stem cell transplantation
Jean El Cheikh, Radwan Massoud, Basel Haffar, Elie Fares, Rami Mahfouz, Tamima Jisr, Mohamed A. Kharfan-Dabaja, Anas Mougharbel, Ali Youssef, Ali Bazarbachi & Ahmad Ibrahim
Pages: 2745-2747
Published online: 28 Mar 2017
First Page PreviewforBendamustine as a bridge to allogeneic transplant in relapsed/refractory Hodgkin lymphoma patients who failed salvage brentuximab vedotin postautologous peripheral blood stem cell transplantation | Full Text | References | PDF (316.5 KB) | Supplemental
  • 420 Views
  • 3 CrossRef citations
  • 0Altmetric
Regression of methotrexate-resistant AIDS-related primary central nervous system lymphoma with lenalidomide plus combination anti-retroviral therapy
Neel K. Gupta, Chia-Ching Wang, Gabriel N. Mannis, John-Paul J. Yu & James L. Rubenstein
Pages: 2748-2751
Published online: 10 Apr 2017
First Page PreviewforRegression of methotrexate-resistant AIDS-related primary central nervous system lymphoma with lenalidomide plus combination anti-retroviral therapy | Full Text | References | PDF (574.5 KB) | Supplemental
  • 279 Views
  • 3 CrossRef citations
  • 0Altmetric
Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study
Emanuela Messa, Lucia Biale, Anna Castiglione, Monia Lunghi, Margherita Bonferroni, Flavia Salvi, Bernardino Allione, Dario Ferrero, Chiara Calabrese, Marco De Gobbi, Paolo Nicoli, Daniela Gioia, Alessandro Levis, Giuseppe Saglio & Daniela Cilloni
Pages: 2752-2754
Published online: 09 May 2017
First Page PreviewforErythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study | Full Text | References | PDF (399.4 KB) | Supplemental
  • 278 Views
  • 10 CrossRef citations
  • 0Altmetric
Intensity-modulated involved-site radiation therapy for non-Hodgkin lymphoma of the head and neck
Zachary David Guss, Abdossalam Madkhali, Qinyu Chen, Yin Zhang, Samson Dah, Joseph Moore & Stephanie Alicia Terezakis
Pages: 2755-2757
Published online: 09 May 2017
First Page PreviewforIntensity-modulated involved-site radiation therapy for non-Hodgkin lymphoma of the head and neck | Full Text | References | PDF (755.3 KB) | Supplemental
  • 124 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Using low-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor in a priming induction therapy for acute myeloid leukemia: a retrospective study of 29 cases in china
Haihui Liu, Jingjing Zhang, Saisai Ren, Mingtai Chen, Lulu Liu & Hao Zhang
Pages: 2758-2761
Published online: 13 Apr 2017
First Page PreviewforUsing low-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor in a priming induction therapy for acute myeloid leukemia: a retrospective study of 29 cases in china | Full Text | References | PDF (414.4 KB) | Supplemental
  • 123 Views
  • 2 CrossRef citations
  • 0Altmetric
Targeting peroxisome proliferator-activated receptors: a novel strategy for Philadelphia chromosome-positive leukemia cells
Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka & Kazuma Ohyashiki
Pages: 2762-2764
Published online: 15 May 2017
First Page PreviewforTargeting peroxisome proliferator-activated receptors: a novel strategy for Philadelphia chromosome-positive leukemia cells | Full Text | References | PDF (876.6 KB) | Supplemental
  • 92 Views
  • 0 CrossRef citations
  • 0Altmetric
Involvement of a member of the histone cluster 1 at 6p21 in NUP98-positive MDS/AML
Danika Di Giacomo, Valentina Pierini, Roberta La Starza, Erika Borlenghi, Fabrizia Pellanera, Anair Graciela Lema Fernandez, Daniela Bellotti, Cinzia Lamorgese, Giuseppe Rossi & Cristina Mecucci
Pages: 2765-2767
Published online: 09 May 2017
First Page PreviewforInvolvement of a member of the histone cluster 1 at 6p21 in NUP98-positive MDS/AML | Full Text | References | PDF (701.7 KB) | Supplemental
  • 153 Views
  • 0 CrossRef citations
  • 0Altmetric
Evaluation of serum erythropoietin values as defined by 2016 World Health Organization criteria for the diagnosis of polycythemia vera
Richard T. Silver, Spencer Krichevsky, Stefani Gjoni & Nicholas C. P. Cross
Pages: 2768-2769
Published online: 20 Mar 2017
CitationforEvaluation of serum erythropoietin values as defined by 2016 World Health Organization criteria for the diagnosis of polycythemia vera | Full Text | References | PDF (252.6 KB) | Supplemental
  • 323 Views
  • 4 CrossRef citations
  • 0Altmetric
Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report
Federica Cocito, Silvia Mangiacavalli, Paolo Bernasconi, Anna A. Colombo, Daniela Caldera, Claudio S. Cartia, Maya Ganzetti, Daniela Troletti, Mario Cazzola & Alessandro Corso
Pages: 2770-2771
Published online: 13 Mar 2017
CitationforLong-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report | Full Text | References | PDF (247.3 KB) | Supplemental
  • 228 Views
  • 1 CrossRef citations
  • 0Altmetric

Corrigenda

Correction
Corrigendum
Page: 2772
Published online: 09 Apr 2017
CitationforCorrigendum | Full Text | PDF (90.9 KB)
  • 382 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles